The cancer-promoting activities of HIF-1 can be suppressed by various agents either directly interacting with HIF-1 molecules or targeting pathways that regulate HIF-1 via microRNAs, transcriptional factors, chaperones, protein kinase cascades, etc. (see [16,100] for a review). This evidence concerns the gene WEE1 and cancer.